MenaQ7
 Zyflamed
 Immunity
 Gabamox
 
 
        Activities                    
   
  Activites > News
 
 
14 December 2011
Nattopharma reports successes on the patent front

NattoPharma ASA has successfully defended two of its European patent applications relating to new uses of vitamin K in treating or preventing cardiovascular diseases before the European Patent Office. The grant of these patents is expected in the first half of 2011. This will strenghten NattoPharma\\\'s IPR and commercial plattform significantly.

read more >>

 
  Omicron Pharmaceuticals | 2017 | All rights reserved